Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00624156 · ClinicalTrials.gov registry record
Expressive Writing and Adjustment to Metastatic Breast Cancer
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 98
- Enrollment target
NCT00624156: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00624156 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 98 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00624156 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 98 participants
- Enrollment target
Study Summary
We are doing this study to see if writing about life experiences helps women adjust to breast cancer that has spread. We will compare two groups. One group will write about their breast cancer experience. The other will write about their daily activities. What we learn from this study may help us to find new ways to help women cope with breast cancer that has spread.
Interventions
- BEHAVIORAL Writing Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 98 participants |
| Start Date | 2008-02 |
| Est. Completion | 2012-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00624156
The ClinicalTrials.gov registry entry for NCT00624156 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 98 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Writing Intervention is the first listed.
NCT00624156 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00624156 about?
NCT00624156 is a clinical study titled "Expressive Writing and Adjustment to Metastatic Breast Cancer". We are doing this study to see if writing about life experiences helps women adjust to breast cancer that has spread. We will compare two groups. One group will write about their breast cancer experience. The other will write about their daily activities. What we learn from this study may help us to...
What is the current status of trial NCT00624156?
This trial is currently completed. The enrollment target is 98 participants. The study started on 2008-02. Estimated completion is 2012-01.
What interventions are being tested in trial NCT00624156?
The interventions under investigation include: Writing Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT00624156?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.